![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/04\/2108-1587394535-1.png\")
<\/p>\n<\/p>\n
![\"diabetes-device-market2020\"](\"https:\/\/pressrelease.icrowdnewswire.com\/assets\/source\/users\/2108\/diabetes-device-market2020.png?1587394451938\")
<\/p>\n
Based on current analysis, the global diabetes devices market was valued at USD21.93 billion in 2018 and is expected to reach USD 38.53 billion by 2026, at a CAGR 7.3% Rising awareness about therapeutics for diabetes and diabetes management among patients is strengthening growth of the market. Continuous technological developments and advancements in the product is another factor expected to create potential opportunities in the market and continue over the forecast period. The diabetes devices offer a solution to diabetes affected patients manage the sugar level in the blood. diabetes device are devices used for checking the sugar level in the blood, it is also used to control glycemic improvement and reduction in hypoglycemia.<\/p>\n
<\/p>\n
Diabetes Devices Market Size – USD 21.93 Billion in 2018, Growth – CAGR of 7.3%, Trends – Product Launches and Research for Advanced Tech Developments<\/strong><\/p>\n <\/strong><\/p>\n To look at the PDF Sample Report and get 30 minutes of a free consultation @ https:\/\/www.reportsanddata.com\/sample-enquiry-form\/1488<\/a> <\/strong><\/p>\n <\/strong><\/p>\n Moreover, multiplying prevalence of diabetes, rising awareness regarding diabetes care, growing intensity of obesity and technological progressions are further fueling the market growth of diabetes devices. According to WHO, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese. Obese population are likely to be detected with type 1, type 2 or gestational diabetes. This information helps us to understand that diabetes market is growing at an increasing rate due to market drivers mentioned above.<\/p>\n <\/strong><\/p>\n Companies profiled for this market study<\/strong><\/p>\n Medtronic, Insulet, Dexcom, Sanofi, Tandem, Ypsomed, Eli Lilly, Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A\/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.<\/p>\n <\/strong><\/p>\n Segments covered in this market study<\/strong><\/p>\n Type (Revenue in USD Million; 2016–2026)<\/strong><\/p>\n <\/p>\n Distribution Channels (Revenue in USD Million; 2016–2026)<\/strong><\/p>\n <\/p>\n Regional Outlook (Revenue in USD Million; 2016–2026)<\/strong><\/p>\n <\/strong><\/p>\n Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies @ https:\/\/www.reportsanddata.com\/report-detail\/diabetes-device-market<\/a><\/strong><\/p>\n <\/p>\n Key findings from the report<\/u><\/strong><\/p>\n <\/strong><\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/strong><\/p>\n Avail this report at Attractive Discount rates! Click here to know more @ https:\/\/www.reportsanddata.com\/discount-enquiry-form\/1488<\/a> <\/strong><\/p>\n John Watson Tags: <\/a>, Diabetes Devices Market Growth<\/a>, Diabetes Devices Market<\/a>, Diabetes Devices Market Analysis<\/a>, Diabetes Devices Market Forecast<\/a><\/p>\n Tags:<\/b> John Watson\n
\n
\n
\n
\n
\n
\n
\n
\n
\nHead of Business Development
\nReports and Data
\n40 Wall St. 28th floor New York City, NY 10005 United States
\nDirect Line: 1-212-710-1370
\nE-mail: sales@reportsanddata.com<\/p>\nSee Campaign: <\/strong>https:\/\/www.reportsanddata.com\/report-detail\/diabetes-device-market<\/a>
Contact Information:<\/b>
John Watson
\nHead of Business Development
\nReports and Data
\n40 Wall St. 28th floor New York City, NY 10005 United States
\nDirect Line: +1-212-710-1370
\nE-mail: sales@reportsanddata.com<\/p>\n
<\/a>, News<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nHead of Business Development
\nReports and Data
\n40 Wall St. 28th floor New York City, NY 10005 United States
\nDirect Line: +1-212-710-1370
\nE-mail: sales@reportsanddata.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"Based on current analysis, the global diabetes devices market was valued at USD21.93 billion in 2018 and is expected to reach USD 38.53 billion by 2026, at a CAGR 7.3% Rising awareness about therapeutics for diabetes and diabetes management among patients is strengthening growth of the market. Continuous technological developments and advancements in the product … Continue reading Diabetes Devices Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies<\/span><\/a> Continue Reading